Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

Province expands Trikafta medication eligibility to young Manitobans

Jackie Snarr’s grandson lives with cystic fibrosis. Snarr reacted on Wednesday to the province’s announcement to open up Trikafta eligibility to children age 6 and up. Previously the eligibility for access to Trikafta, a drug used to treat cystic fibrosis, was 12 and up. This change comes after the Canadian Agency for Drugs and Technologies in Health recommended an adjustment to allow younger children to access the drug last month.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article